Eversana Life Science Services Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Eversana Life Science Services Pharmaceutical Import Records from India — 51 Products, $263.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Eversana Life Science Services — Pharmaceutical Importer Profile (2026) | 51 Products, $263.6M Trade | TransData Nexus

Eversana Life Science Services

Pharmaceutical Importer · United States · Cardiovascular Focus · $263.6M Total Trade · DGFT Verified

Eversana Life Science Services is a pharmaceutical importer based in United States with a total trade value of $263.6M across 51 products in 19 therapeutic categories. Based on 5,862 verified import shipments from Indian Customs (DGFT) records, Eversana Life Science Services is the #1 buyer in 17 products including Iron, Carvedilol, Losartan. Eversana Life Science Services sources from 15 verified Indian suppliers, with Zydus Lifesciences Limited accounting for 59.9% of imports.

Eversana Life Science Services — Import Portfolio & Supplier Network

Eversana Life Science Services import network — 51 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Eversana Life Science Services?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Zydus Lifesciences Limited	$199.7M	6,325	59.9%
Cadila Healthcare Limited	$56.1M	1,447	16.8%
Micro Labs Limited

What Formulations Does Eversana Life Science Services Import?

Formulation	Value	Ships
Pharmaceutical medicine for human use	$3.7M	99
Tamsulosin hcl CAPS USP 0.4 MG	$1.9M	39
Pharmaceutical medicine for human use	$1.9M	56
Pharmaceutical medicine for human use	$1.9M	49
Pharmaceutical medicine for human use	$1.9M	49
Pharma medicine for human	$1.8M	51
Ketorolac tromethamine injection USP 30MG/ML (30MG/ML)	$1.8M	36
Mesalamine delayed release tablets 1.2	$1.8M	35
Pharmaceutical medicine for human use	$1.7M	40
Tamsulosin hcl CAPS USP 0.4MG	$1.6M	32
Ketorolac tromethamine injection USP 30MG/ML (30MG/ML	$1.6M	42
Omeprazole dr CAPS USP 40 MG 1 x	$1.5M	37
Pharma medicine for human	$1.5M	39
Ketorolac tromethamine injection USP 30MG/ML 30MG/ML	$1.4M	29
Oseltamivir phosphate for oral	$1.4M	27

Eversana Life Science Services imports 4,429 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 30 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Iron	Vitamins & Supplements	$24.1M	481	4.9%	1
2	Carvedilol	Cardiovascular	$19.3M	498	19.7%	1
3	Losartan	Cardiovascular	$18.3M	365	6.1%	1
4	Mesalamine	Gastrointestinal	$16.1M	321	1.2%	1
5	Spironolactone	Diuretics	$15.8M	317	8.0%	1
6	Ketorolac	Analgesics & Antipyretics	$12.4M	249	10.7%	1
7	Potassium	Nutritional Supplements	$12.1M	241	1.9%	1
8	Chloroquine	Antimalarial & Antiparasitic	$10.3M	207	5.8%	1
9	Hydroxychloroquine	Antimalarial & Antiparasitic	$10.3M	207	7.1%	1
10	Metformin	Diabetes & Endocrine	$10.2M	203	2.2%	8
11	Fluconazole	Antifungals	$9.4M	188	10.2%	1
12	Omeprazole	Gastrointestinal	$8.7M	174	1.4%	9
13	Nystatin	Antifungals	$8.0M	225	12.8%	2
14	Meloxicam	Analgesics & Antipyretics	$6.8M	165	3.4%	4
15	Azithromycin	Antibiotics	$5.8M	141	3.1%	4
16	Azathioprine	Immunosuppressants	$5.2M	104	15.4%	1
17	Acyclovir	Antivirals	$4.6M	125	3.7%	7
18	Methylprednisolone	Corticosteroids	$4.4M	136	15.1%	1
19	Prednisolone	Respiratory	$4.4M	136	4.6%	5
20	Oseltamivir	Antivirals	$4.4M	88	3.6%	1
21	Leflunomide	Immunosuppressants	$4.3M	87	29.3%	1
22	Anastrozole	Advanced Oncology	$3.7M	89	3.4%	2
23	Doxycycline	Antibiotics	$3.3M	66	2.8%	1
24	Allopurinol	Lipid & Metabolism	$3.1M	63	0.6%	6
25	Clindamycin	Antibiotics	$3.1M	84	3.4%	8
26	Metronidazole	Advanced Antibiotics	$3.0M	79	1.5%	5
27	Atenolol	Cardiovascular	$2.8M	100	6.8%	2
28	Ondansetron	Gastrointestinal	$2.6M	54	2.1%	12
29	Gabapentin	CNS & Psychiatric	$2.5M	51	0.3%	5
30	Verapamil	Cardiovascular	$2.4M	48	2.2%	2

Eversana Life Science Services imports 51 pharmaceutical products across 19 categories into United States totaling $263.6M. The company is the #1 buyer for 17 products: Iron, Carvedilol, Losartan, Mesalamine, Spironolactone.

Eversana Life Science Services — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Eversana Life Science Services LLC is a leading independent provider of global services to the life sciences industry, offering integrated solutions that span all stages of the product lifecycle. The company is headquartered in Milwaukee, Wisconsin, and serves over 650 organizations, including both innovative start-ups and established pharmaceutical companies. Their services are rooted in the patient experience, aiming to deliver long-term, sustainable value for patients, prescribers, channel partners, and payers.

In 2018, Eversana unified several premier service providers, including Dohmen Life Science Services, The Access Group, Alliance Life Sciences, Health Strategies Group, Triplefin, and Patient Experience Project, under its brand. This consolidation enabled Eversana to offer a comprehensive suite of services, such as management and regulatory strategy, marketing, distribution and logistics, patient engagement and support, pharmacovigilance, medical communication, and safety, as well as research, global pricing software, and analytics.

2Distribution Network

Eversana operates a robust distribution network with multiple locations across North America, Europe, and Asia Pacific. This extensive network enables the company to provide comprehensive commercialization, logistics, and consulting solutions for pharmaceutical and biotech companies, supporting every stage of the product lifecycle.

3Industry Role

Eversana Life Science Services functions as a comprehensive service provider within the pharmaceutical supply chain. While it does not act as a traditional wholesaler or distributor, the company offers integrated solutions that encompass commercialization, logistics, and consulting services. This approach supports pharmaceutical and biotech companies throughout the entire product lifecycle, from launch readiness to in-market products.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Eversana Life Science Services

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Eversana's sourcing strategy demonstrates a significant concentration in its supplier base, with Zydus Lifesciences Limited accounting for 59.9% of the total import value from India. This heavy reliance on a single supplier indicates a strategic choice to leverage Zydus's capabilities, potentially securing favorable terms and ensuring a consistent supply of pharmaceutical formulations. However, such concentration also introduces risks related to supply chain disruptions, quality control, and regulatory compliance. The substantial number of shipments (6,325) from Zydus suggests a stable and ongoing relationship, yet the lack of diversification could pose challenges if issues arise with this supplier.

2Supply Chain Resilience

Eversana's supply chain resilience is closely tied to its primary supplier, Zydus Lifesciences Limited. The company's heavy reliance on this single source for a significant portion of its imports from India indicates a potential vulnerability. While the extensive number of shipments suggests a stable relationship, the lack of backup suppliers and limited diversification in formulations imported from India could expose Eversana to risks associated with supply chain disruptions, quality control issues, and regulatory compliance challenges. To enhance resilience, Eversana may consider diversifying its supplier base and increasing the variety of formulations sourced from India.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and marketing of pharmaceutical products. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which sets forth requirements for drug approval, labeling, and manufacturing practices. The FDA's Center for Drug Evaluation and Research (CDER) is responsible for evaluating new drugs and ensuring they meet safety and efficacy standards. For Indian generics to enter the U.S. market, they must undergo the Abbreviated New Drug Application (ANDA) process, demonstrating bioequivalence to the reference listed drug.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the U.S. market include obtaining an FDA registration for the establishment and listing of the drug products. Manufacturers must comply with Good Manufacturing Practice (GMP) regulations, which ensure that products are consistently produced and controlled according to quality standards. The FDA recognizes GMP certifications from other regulatory bodies, such as the European Medicines Agency (EMA) and the World Health Organization (WHO), provided they meet FDA standards. Wholesale distributors must obtain a state-specific license to operate legally within each state they serve.

Eversana Life Science Services — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Eversana's focus on importing pharmaceutical formulations in therapeutic areas such as cardiovascular, gastrointestinal, and vitamins & supplements aligns with market demand for these treatments. The company's top five imported products—iron, carvedilol, losartan, mesalamine, and spironolactone—are commonly used in these therapeutic categories, indicating a strategic emphasis on addressing prevalent health conditions. This product strategy reflects Eversana's commitment to providing essential medications that meet the needs of patients and healthcare providers.

2Sourcing Profile

Eversana's sourcing strategy primarily focuses on generic drug formulations, with a significant portion imported from India. The company's preference for specific formulations, such as iron, carvedilol, and losartan, suggests a targeted approach to procurement, aiming to meet the therapeutic needs of the U.S. market. India's established pharmaceutical manufacturing capabilities and cost-effectiveness make it a strategic partner for Eversana in sourcing these formulations.

3Market Positioning

Based on its product mix, Eversana Life Science Services serves a diverse segment of the U.S. pharmaceutical market, including retail pharmacies, hospitals, and wholesale distribution channels. The company's focus on essential medications across various therapeutic areas positions it to meet the needs of different healthcare settings, ensuring broad access to critical treatments for patients.

Seller's Guide — How to Become a Supplier to Eversana Life Science Services

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Eversana Life Science Services, particularly in therapeutic areas where Eversana seeks to diversify its sourcing. Identifying gaps in Eversana's current sourcing, such as underrepresented formulations or emerging therapeutic areas, presents an opportunity for Indian exporters to offer alternative products. Establishing relationships with Eversana could lead to mutually beneficial partnerships, enhancing supply chain resilience and expanding market reach.

2Requirements & Qualifications

Indian exporters aiming to supply Eversana Life Science Services and the U.S. market must adhere to FDA regulations, including obtaining necessary import registrations and ensuring compliance with GMP standards. Products must undergo batch testing and stability studies to meet FDA requirements. Labeling must be in English and include all mandated information. Additionally, exporters should be prepared to meet serialization mandates and provide detailed documentation to facilitate regulatory approval.

3How to Approach

Frequently Asked Questions — Eversana Life Science Services

Who supplies pharmaceutical formulations to Eversana Life Science Services from India?

Who supplies pharmaceutical formulations to Eversana Life Science Services from India? Eversana sources finished pharmaceutical formulations from several Indian manufacturers, including Zydus Lifesciences Limited, Cadila Healthcare Limited, and Micro Labs Limited. These suppliers provide a range of products across various therapeutic categories.

How much does Eversana Life Science Services import in pharmaceutical formulations from India?

How much does Eversana Life Science Services import in pharmaceutical formulations from India? Between 2022 and 2026, Eversana imported pharmaceutical formulations from India valued at approximately $263.6 million USD, encompassing 5,862 shipments. This substantial import volume underscores the company's reliance on Indian pharmaceutical products.

What pharmaceutical products does Eversana Life Science Services import?

What pharmaceutical products does Eversana Life Science Services import? Eversana imports a diverse portfolio of 51 pharmaceutical products across 19 therapeutic categories. Notably, their top five imported products include Iron supplements ($24.1M), Carvedilol ($19.3M), Losartan ($18.3M), Mesalamine ($16.1M), and Spironolactone ($15.8M).

Which Indian pharmaceutical companies are verified suppliers to Eversana Life Science Services?

Which Indian pharmaceutical companies are verified suppliers to Eversana Life Science Services? Verified Indian suppliers to Eversana include Zydus Lifesciences Limited, Cadila Healthcare Limited, Micro Labs Limited, Gland Pharma Limited, and Rubicon Research Private Limited. These companies collectively account for the majority of Eversana's imports from India.

Get Full Eversana Life Science Services Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 3 company name variants from customs records. For current shipment-level data, contact TransData Nexus.

Eversana Life Science Services

Eversana Life Science Services — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Eversana Life Science Services?

What Formulations Does Eversana Life Science Services Import?

What Products Does Eversana Life Science Services Import?

Top Products by Import Value

Eversana Life Science Services Therapeutic Categories — 19 Specializations

Import Portfolio — Top 30 by Import Value

All 51 Products

Key Metrics

Top Categories

Indian Suppliers

Related Trade Data

Need Detailed Data?